Patients who switch inhaler therapies tend to have a difficult time. Do you think that reinforcing inhaler technique through patient education at the time of the switch is effective?
We want to hear about your experiences during the COVID-19 pandemic. Take our poll to let us know how the pandemic has affected you, your staff, and your patients.
Do you think immune modulatory therapy is a viable option for individuals with refractory adult-onset epilepsy who also develop psychiatric or cognitive impairment? Let us know by taking our poll.
EULAR updated its recommendations for treating rheumatoid arthritis with different therapeutic agents. Do you agree with its recommendation about initiating therapy for patients with RA?
